Your session is about to expire
← Back to Search
Enhanced Telemedicine for Chronic Childhood Diseases
N/A
Recruiting
Led By Ricardo A Mosquera, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Greater than or equal to 2 hospitalizations or greater than or equal to 1 ICU admission in the year before joining the comprehensive care program
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study(about 24 months)
Awards & highlights
Study Summary
This trial will test if adding a telemedicine program to comprehensive care can improve outcomes for children with medical complexity.
Who is the study for?
This trial is for children with complex chronic diseases who have been hospitalized multiple times or admitted to the ICU at least once in the past year. They should be considered at high risk of future hospitalization without specialized care, but can't participate if they have major heart disease, mitochondrial disorders, active cancer, a DNR order, or are receiving compassionate end-of-life care.Check my eligibility
What is being tested?
The study is testing whether an enhanced telemedicine program (ETM) that includes remote examination devices can improve care for these children when added to comprehensive care (CC). ETM allows doctors to check vital signs and examine patients through mobile devices from home.See study design
What are the potential side effects?
Since this trial involves non-invasive monitoring via telemedicine rather than medication or invasive procedures, there are no direct side effects associated with the interventions being tested.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I've been hospitalized at least twice or admitted to the ICU once in the past year.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of study(about 24 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study(about 24 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of days care provided in a medical setting
Total number of episodes of serious illnesses (causing death, pediatric ICU admission, and hospital stay > 7d).
Secondary outcome measures
All cause infections on admission to the hospital
Cost effectiveness of ETM
Parent ratings of care assessed using the Consumer Assessment of Healthcare Providers and Systems Survey
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: comprehensive care (CC) augmented with enhanced telemedicine (ETM)Experimental Treatment2 Interventions
Group II: usual CC (with conventional telemedicine)Active Control1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,697 Total Patients Enrolled
Children and Youth with Special Health Care Needs National Research Network (CYSHC)UNKNOWN
Ricardo A Mosquera, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
143 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I've been hospitalized at least twice or admitted to the ICU once in the past year.I have a significant heart condition.I have a mitochondrial disorder.My cancer is currently active.
Research Study Groups:
This trial has the following groups:- Group 1: usual CC (with conventional telemedicine)
- Group 2: comprehensive care (CC) augmented with enhanced telemedicine (ETM)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any vacancies available in this medical experiment?
"Per clinicaltrials.gov, enrollment for this particular trial has been paused since June 6th 2022 when the last update was posted. In spite of this inactivity there are 78 other medical studies actively recruiting participants at present time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger